HUP0302330A3 - Praziquantel compositions for treating diseases due to sarcocystis, neospora, toxoplasma and isospora - Google Patents

Praziquantel compositions for treating diseases due to sarcocystis, neospora, toxoplasma and isospora

Info

Publication number
HUP0302330A3
HUP0302330A3 HU0302330A HUP0302330A HUP0302330A3 HU P0302330 A3 HUP0302330 A3 HU P0302330A3 HU 0302330 A HU0302330 A HU 0302330A HU P0302330 A HUP0302330 A HU P0302330A HU P0302330 A3 HUP0302330 A3 HU P0302330A3
Authority
HU
Hungary
Prior art keywords
sarcocystis
neospora
isospora
praziquantel
toxoplasma
Prior art date
Application number
HU0302330A
Other languages
English (en)
Original Assignee
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp filed Critical Bayer Corp
Publication of HUP0302330A2 publication Critical patent/HUP0302330A2/hu
Publication of HUP0302330A3 publication Critical patent/HUP0302330A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HU0302330A 2000-05-23 2001-05-18 Praziquantel compositions for treating diseases due to sarcocystis, neospora, toxoplasma and isospora HUP0302330A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/576,791 US6429211B1 (en) 2000-05-23 2000-05-23 Praziquantel compounds for treating diseases due to Sarcocystis Neospora Toxoplasma and Isospora
PCT/US2001/016440 WO2001089497A2 (en) 2000-05-23 2001-05-18 Praziquantel compositions for treating diseases due to sarcocystis, neospora, toxoplasma and isospora

Publications (2)

Publication Number Publication Date
HUP0302330A2 HUP0302330A2 (hu) 2003-11-28
HUP0302330A3 true HUP0302330A3 (en) 2012-02-28

Family

ID=24306001

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302330A HUP0302330A3 (en) 2000-05-23 2001-05-18 Praziquantel compositions for treating diseases due to sarcocystis, neospora, toxoplasma and isospora

Country Status (19)

Country Link
US (2) US6429211B1 (hu)
EP (1) EP1296686B1 (hu)
JP (1) JP4991076B2 (hu)
KR (1) KR100821112B1 (hu)
CN (1) CN1250222C (hu)
AT (1) ATE310521T1 (hu)
AU (1) AU2001274886A1 (hu)
BR (1) BR0111014A (hu)
CA (1) CA2409926C (hu)
DE (1) DE60115237T2 (hu)
DK (1) DK1296686T3 (hu)
ES (1) ES2252242T3 (hu)
HK (1) HK1059894A1 (hu)
HU (1) HUP0302330A3 (hu)
MX (1) MXPA02011453A (hu)
NZ (1) NZ522687A (hu)
PL (1) PL202041B1 (hu)
WO (1) WO2001089497A2 (hu)
ZA (1) ZA200208770B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006061214A1 (en) * 2004-12-10 2006-06-15 Bayer Healthcare Ag Anthelmintic composition
US8563554B2 (en) 2009-03-17 2013-10-22 Concert Pharmaceuticals, Inc. Deuterated pyrazinoisoquinoline compounds
US10137111B2 (en) 2016-08-11 2018-11-27 Adamis Pharmaceuticals Corporation Drug compositions comprising an anti-parasitic and proton pump inhibitor
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions
US20200138823A1 (en) * 2018-11-02 2020-05-07 Adamis Pharmaceuticals Corporation Drug compositions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2362539C2 (de) 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4447414A (en) 1982-12-21 1984-05-08 Cutter Laboratories, Inc. Carnivore anthelmintics
DE3634755A1 (de) * 1986-10-11 1988-04-14 Bayer Ag Dermale behandlung von wurmerkrankungen der katze mit praziquantel
DE3805660A1 (de) 1988-02-24 1989-09-07 Bayer Ag Substituierte 1,2,4-triazindione, verfahren zu ihrer herstellung und ihre verwendung
DE3826058A1 (de) 1988-07-30 1990-02-08 Bayer Ag Mittel gegen fischparasiten
US4933341A (en) 1988-10-08 1990-06-12 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
US5196562A (en) 1988-10-08 1993-03-23 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
EP0377903A3 (de) 1989-01-09 1991-07-17 Bayer Ag Substituierte Hexahydro-1,2,4-triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
CN1044905A (zh) 1989-02-16 1990-08-29 赫彻斯特股份公司 鱼和昆虫寄生虫对抗剂
DE4030042A1 (de) 1990-05-17 1991-11-21 Bayer Ag Verwendung von substituierten 1,2,4-triazindionen
DE4120138A1 (de) 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
AUPM969994A0 (en) 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
US5663155A (en) 1994-11-30 1997-09-02 The University Hospital Compositions for the treatment of parasitic infections
JPH0987196A (ja) * 1995-09-25 1997-03-31 Masatoshi Nakano 寄生虫駆除・駆虫剤
US6051604A (en) * 1995-12-07 2000-04-18 The Proctor & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US6180604B1 (en) * 1996-08-21 2001-01-30 Micrologix Biotech Inc. Compositions and methods for treating infections using analogues of indolicidin
AU5529600A (en) * 1999-06-18 2001-01-09 Bayer Aktiengesellschaft Anthelmintic compositions

Also Published As

Publication number Publication date
NZ522687A (en) 2004-07-30
EP1296686B1 (en) 2005-11-23
PL202041B1 (pl) 2009-05-29
DE60115237T2 (de) 2006-06-29
DK1296686T3 (da) 2006-04-03
CN1452489A (zh) 2003-10-29
PL360503A1 (en) 2004-09-06
HK1059894A1 (en) 2004-07-23
DE60115237D1 (de) 2005-12-29
ES2252242T3 (es) 2006-05-16
US20020143018A1 (en) 2002-10-03
MXPA02011453A (es) 2003-05-23
ATE310521T1 (de) 2005-12-15
WO2001089497A3 (en) 2002-11-28
BR0111014A (pt) 2003-04-08
KR20020097257A (ko) 2002-12-31
CA2409926A1 (en) 2001-11-29
US6429211B1 (en) 2002-08-06
AU2001274886A1 (en) 2001-12-03
ZA200208770B (en) 2003-10-30
CA2409926C (en) 2009-11-03
JP4991076B2 (ja) 2012-08-01
HUP0302330A2 (hu) 2003-11-28
WO2001089497A2 (en) 2001-11-29
JP2003534275A (ja) 2003-11-18
EP1296686A2 (en) 2003-04-02
CN1250222C (zh) 2006-04-12
KR100821112B1 (ko) 2008-04-11

Similar Documents

Publication Publication Date Title
AU5752601A (en) Splice-region antisense composition and method
PL362597A1 (en) Improved protection tampon and method of making
HUP0302578A3 (en) Isoindole-imide compounds, compositions containing them, and use thereof
AU6832101A (en) Composition and method
IL154534A0 (en) Cathartic composition
GB0126990D0 (en) Method and composition for improving fuel consumption
EP1139993A4 (en) HIGH WATER DENTIFRANT COMPOSITION AND METHOD OF MANUFACTURE
AU4163402A (en) Composition and method
AU142356S (en) Closure
AU2003287675A8 (en) Absorbent neck shield
AU7311501A (en) Cosmetic composition and method
EP1202060A4 (en) BIOSENSOR AND MANUFACTURING METHOD
HK1057222A1 (en) Improved rubber composition
GB0004582D0 (en) Mapping circuitry and method
IL153687A0 (en) Composition and method for enhancing elasticity of tissue
HUP0302330A3 (en) Praziquantel compositions for treating diseases due to sarcocystis, neospora, toxoplasma and isospora
AU7522401A (en) Non-agonistic antibodies to human gp39, compositions containing, and therapeuticuse thereof
AU2198100A (en) Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
PL350902A1 (en) Pyridothiene diazepins, method of obtaining them and pharmacological compositions containing them
PL348936A1 (en) Novel compounds of benzothiadiazine, method of obtaining them and pharmacological compositions containing such compounds
HUP0302670A3 (en) Closure cap
GB0028706D0 (en) Cosmetic composition
EP1272512A4 (en) IMMUNOKIN COMPOSITION AND METHOD
GB2361188B (en) Introducing sensors into soft tissue
AU5507999A (en) Monocyclic compounds having nk-2 antagonist action and compositions containing them

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees